Cargando…

Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer

SIMPLE SUMMARY: Small molecules that inhibit cyclin dependent kinases (CDKs) have great potential for the treatment of breast cancer and have been implemented in the standard of care for some patients with metastatic disease. As the indications for CDK inhibitors continue to expand, and it is crucia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decker, Joseph T., Ma, Jeffrey A., Shea, Lonnie D., Jeruss, Jacqueline S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582459/ https://www.ncbi.nlm.nih.gov/pubmed/34771508 http://dx.doi.org/10.3390/cancers13215343

Ejemplares similares

Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer
por: Rao, Shreyas S., et al.
Publicado: (2017)

Precision health for breast cancer metastasis: biomaterial scaffolds as an engineered metastatic niche to define, study, and monitor metastatic progression
por: Bushnell, Grace G., et al.
Publicado: (2019)

Dynamic Transcription Factor Networks in Epithelial-Mesenchymal Transition in Breast Cancer Models
por: Siletz, Anaar, et al.
Publicado: (2013)

A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs
por: Wang, Jing, et al.
Publicado: (2023)

Engineering the pre-metastatic niche
por: Aguado, Brian A., et al.
Publicado: (2017)

Breast cancer prevention by short-term inhibition of TGFβ signaling
por: Alečković, Maša, et al.
Publicado: (2022)

4026 Dissecting the role of microenvironment heterogeneity on metastatic tumor cell phenotype at an engineered metastatic niche
por: Orbach, Sophia, et al.
Publicado: (2020)

LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells
por: Li, Nian-Shuang, et al.
Publicado: (2015)

Dynamic, Large-Scale Profiling of Transcription Factor Activity from Live Cells in 3D Culture
por: Weiss, Michael S., et al.
Publicado: (2010)

CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2013)

SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
por: Tang, Xiaolong, et al.
Publicado: (2017)

TGF-β1 induces HMGA1 expression in human breast cancer cells: Implications of the involvement of HMGA1 in TGF-β signaling
por: ZU, XUYU, et al.
Publicado: (2015)

ERRATUM: CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2014)

TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters
por: Webb, Bryan M., et al.
Publicado: (2021)

TGF-β1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells
por: Utreras, Elias, et al.
Publicado: (2013)

GPR50 in TGFβ signaling and breast cancer
por: Ahmad, Raise, et al.
Publicado: (2018)

The functional switch of TGF-β signaling in breast cancer
por: Shi, Qiaoni, et al.
Publicado: (2019)

Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
por: Suriyamurthy, Sudha, et al.
Publicado: (2019)

TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
por: Hiew, Lih-Fhung, et al.
Publicado: (2021)

TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies
por: Hachana, Soumaya, et al.
Publicado: (2022)

Inhibition of TGF-β and NOTCH Signaling by Cutaneous Papillomaviruses
por: Meyers, Jordan M., et al.
Publicado: (2018)

TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling
por: Tazat, Keren, et al.
Publicado: (2015)

TGF-β Signaling
por: Tzavlaki, Kalliopi, et al.
Publicado: (2020)

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
por: Juárez, Patricia, et al.
Publicado: (2017)

TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson’s Disease
por: Muñoz, Mª Dolores, et al.
Publicado: (2020)

TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
por: Drabsch, Yvette, et al.
Publicado: (2011)

Therapeutic Implications of TGFβ in Cancer Treatment: A Systematic Review
por: Gómez-Gil, Verónica
Publicado: (2021)

Rejuvenation by inhibiting TGF-β1/pSmad signaling
por: Corder, Elizabeth H., et al.
Publicado: (2015)

Inhibition of TGF-β Signaling Promotes Human Pancreatic β-Cell Replication
por: Dhawan, Sangeeta, et al.
Publicado: (2016)

HILI Inhibits TGF-β Signaling by Interacting with Hsp90 and Promoting TβR Degradation
por: Zhang, Kun, et al.
Publicado: (2012)

CDK4/6 inhibition in luminal breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2016)

Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF-β Receptor I in the TGF-β/Smad Signaling Pathway
por: Shi, Qinlin, et al.
Publicado: (2020)

Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions
por: Raghani, Ravi M., et al.
Publicado: (2022)

Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells
por: Zhang, Jing, et al.
Publicado: (2023)

Signal integration in TGF-β, WNT, and Hippo pathways
por: Attisano, Liliana, et al.
Publicado: (2013)

plasticity of TGF-β signaling
por: Cellière, Geraldine, et al.
Publicado: (2011)

Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling
por: Jiang, Zhitao, et al.
Publicado: (2019)

Pinocembrin Ameliorates Skin Fibrosis via Inhibiting TGF-β1 Signaling Pathway
por: Li, Xiaohe, et al.
Publicado: (2021)

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2021)

Recent advances in understanding contextual TGFβ signaling
por: Ayyaz, Arshad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_19r0ru1flc2rn82upbp7vfq92j